Novo Holdings A/S Q3 2023 Filing

Filed November 14, 2023

Portfolio Value

$1353.2T

Holdings

40

Report Date

Q3 2023

Filing Type

13F-HR

All Holdings (40 positions)

#StockSharesValue% PortfolioType
1
BNBROOKFIELD CORP
3,880,230$121.3T8.97%
2
ASMLASML HOLDING N V
197,760$116.4T8.60%
3
CRMSALESFORCE.COM, INC.
530,500$107.6T7.95%
4
HTDCORCEPT THERAPEUTICS INC
3,377,768$92.0T6.80%
5
LNZALANZATECH GLOBAL INC
15,814,845$73.9T5.46%
6
CABOCABLE ONE INC
118,403$72.9T5.39%
7
TSMTAIWAN SEMICONDUCTOR MFG LTD
710,780$61.8T4.56%
8
IRONDISC MEDICINE, INC.
1,090,772$51.2T3.79%
9
MIRMMIRUM PHARMACEUTICALS INC
1,500,000$47.4T3.50%
10
BABAALIBABA GROUP HLDG LTD
500,827$43.4T3.21%
11
PCVXVAXCYTE INC
845,000$43.1T3.18%
12
ACLXARCELLX, INC.
1,075,000$38.6T2.85%
13
AAPLAPPLE INC
221,460$37.9T2.80%
14
BMRNBIOMARIN PHARMACEUTICAL INC
400,000$35.4T2.62%
15
EWTXEDGEWISE THERAPEUTICS INC
6,071,703$34.8T2.57%
16
SGENUSDSEAGEN INC.
159,986$33.9T2.51%
17
IM8NINSMED INC
1,339,304$33.8T2.50%
18
CRNXCRINETICS PHARMACEUTICALS IN
1,100,000$32.7T2.42%
19
PHVSPHARVARIS N V
1,329,325$27.7T2.05%
20
2L9BLUEPRINT MEDICINES CORP
525,000$26.4T1.95%
21
AM6AMICUS THERAPEUTICS INC
2,095,900$25.5T1.88%
22
OKURRENEO PHARMACEUTICALS INC
3,330,377$25.3T1.87%
23
CBAYUSDCYMABAY THERAPEUTICS INC
1,566,521$23.4T1.73%
24
ALNYALNYLAM PHARMACEUTICALS INC
118,383$21.0T1.55%
25
BAMBROOKFIELD ASSET MANAGMT LTD
627,207$20.9T1.55%
26
RCKTROCKET PHARMACEUTICALS INC
1,001,000$20.5T1.52%
27
FDMT4D MOLECULAR THERAPEUTICS IN
1,200,000$15.3T1.13%
28
SPRBSPRUCE BIOSCIENCES INC
6,722,336$15.2T1.12%
29
INSPINSPIRE MED SYS INC
60,000$11.9T0.88%
30
IOBTIO BIOTECH INC
5,747,067$8.1T0.60%
31
RLYBRALLYBIO CORP
2,187,999$7.4T0.54%
32
ABCLABCELLERA BIOLOGICS INC
1,126,915$5.2T0.38%
33
SILKSILK RD MED INC
333,884$5.0T0.37%
34
TMCITREACE MED CONCEPTS INC
360,000$4.7T0.35%
35
LAVA THERAPEUTICS NV
2,400,000$3.5T0.26%
36
MQMARQETA INC
441,558$2.6T0.20%
37
CYTCYTEIR THERAPEUTICS INC
676,379$1.9T0.14%
38
GLTOUSDGALECTO INC
2,497,791$1.8T0.13%
39
KINNATE BIOPHARMA INC
815,707$1.1T0.08%
40
SPROSPERO THERAPEUTICS INC
468,902$567.4B0.04%